Spots Global Cancer Trial Database for in vivo cell survival
Every month we try and update this database with for in vivo cell survival cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes | NCT00393029 | Anti-p53 TCR-Ge... | anti-protein 53... aldesleukin filgrastim cyclophosphamid... fludarabine pho... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes | NCT00393029 | Anti-p53 TCR-Ge... | anti-protein 53... aldesleukin filgrastim cyclophosphamid... fludarabine pho... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes | NCT00393029 | Anti-p53 TCR-Ge... | anti-protein 53... aldesleukin filgrastim cyclophosphamid... fludarabine pho... | 18 Years - | National Institutes of Health Clinical Center (CC) |